Ameriprise
MLNT

Ameriprise’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Ameriprise’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,035
Closed -$240K – 3728
2017
Q4 		$240K Buy
+3,035
New +$240K ﹤0.01% 3407